Sfoglia per AUTORE
HARRISON S
Collezione AOU Città della Salute di Torino

  

Items : 7

2025
AOU Città della Salute di Torino

Mina R; Mylin AK; Yokoyama H; Magen H; Alsdorf W; Minnema MC; Shune L; Isufi I; Harrison SJ; Shah UA; Schecter JM; Vogel M; Lendvai N; Gries KS; Katz EG; Slaughter A; Lonardi C; Gilbert J; Li Q; Deraedt W; Filho OC; Patel N; Florendo E; Karlin L; Weisel K;

acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study. in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association / Clin Gastroenterol Hepatol. 2025 Apr;23(5):785-796. doi: 10.1016/j.cgh.2024.07.045. Epub 2024 Oct 2.
2025
AOU Città della Salute di Torino

Chan MS; Canivet CM; Mahgoub S; Asgharpour A; Lara-Romero C; Teh KKJ; Llop E; Shang Y; de Saint-Loup M; Armandi A; Liu WY; Pennisi G; Fournier-Poizat C; Wong GL; Yip TC; Lee HW; Lin H; Yang S; Wang J; Li L; Zeng QL; Ye Q; Deng H; Liu C; Zhou Y; Yan X; Niu J; Lu Z; Nan Y; et alii...

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease. in JAMA / JAMA. 2024 Apr 16;331(15):1287-1297. doi: 10.1001/jama.2024.1447.
2024
AOU Città della Salute di Torino

Lin H; Lee HW; Yip TC; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng MH; Hagström H; Boursier J; Calleja JL; Goh GB; Chan WK; Gallego-Durán R; Sanyal AJ; de Lédinghen V; Newsome PN; Fan JG; Castéra L; Lai M; Harrison SA; Fournier-Poizat C; Wong GL; Pennisi G; Armandi A; Nakajima A; Liu WY; Shang Y; de Saint-Loup M; et alii...

Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study. in Hepatology (Baltimore, Md.) / Hepatology. 2023 Jul 1;78(1):258-271. doi: 10.1097/HEP.0000000000000364. Epub 2023 Mar 31.
2023
AOU Città della Salute di Torino

Schuppan D; Schattenberg JM; Yunis C; Karsdal M; Torstenson R; Romero-Gomez M; Aithal GP; Bugianesi E; Ekstedt M; Crespo J; Yki-Järvinen H; Holleboom AG; Cobbold J; Leeming DJ; Harrison S; Dufour JF; Pais R; Cortez-Pinto H; Papatheodoridis G; Allison M; Bedossa P; Tiniakos D; Wonders K; Francque S; Geier A; Fournier C; Alexander L; Chen Y; Ostroff R; et alii...

Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses. in Circulation / Circulation. 2022 Nov 15;146(20):1507-1517. doi: 10.1161/CIRCULATIONAHA.122.060700. Epub 2022 Oct 31
2022
AOU Città della Salute di Torino

Tsao PS; Muralidhar S; Pyarajan S; Gagnon DR; Zamora-Ros R; Akwo EA; Yamagishi K; Willeit P; Woodward M; Wannamethee SG; Weiderpass E; Völzke H; Wallace RB; Monique Verschuren WM; van der Schouw YT; Tzoulaki I; Tumino R; Tjønneland A; Tong T; Tikhonoff V; Sieri S; Sundström J; Schulze MB; Sakurai M; Santiuste C; Sacerdote C; Rosengren A; Garcia JRQ; Palmieri L; et alii...

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. in The Lancet. Oncology / Lancet Oncol. 2021 Mar;22(3):e105-e118. doi: 10.1016/S1470-2045(20)30756-7.
2021
AOU Città della Salute di Torino

Moreau P; Kumar SK; San Miguel J; Davies F; Zamagni E; Bahlis N; Ludwig H; Mikhael J; Terpos E; Schjesvold F; Martin T; Yong K; Durie BGM; Facon T; Jurczyszyn A; Sidana S; Raje N; van de Donk N; Lonial S; Cavo M; Kristinsson SY; Lentzsch S; Hajek R; Anderson KC; João C; Einsele H; Sonneveld P; Engelhardt M; Fonseca R; et alii...

Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the Phase III ICARIA-MM study. in Future oncology (London, England) / Future Oncol. 2021 Dec;17(34):4797-4812. doi: 10.2217/fon-2021-0568. Epub 2021 Sep 15.
2021
AOU Città della Salute di Torino

Richardson PG; Harrison SJ; Bringhen S; Schjesvold F; Yong K; Campana F; Le-Guennec S; Macé S; Dimopoulos MA;